Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.

Saved in:
Bibliographic Details
Title: Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.
Authors: Mennini FS; Departments of Healthcare Planning, Medical Devices, Pharmaceuticals, and Policies in Support of the National Health Service, Italian Ministry of Health, Rome, Italy., Cicchetti A; Faculty of Economics, Economic Evaluation and HTA, CEIS, University of Rome 'Tor Vergata', Rome, Italy., Sciattella P; Department of Healthcare Planning, Italian Ministry of Health, Rome, Italy. paolo.sciattella@uniroma2.it., Rumi F; Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, Rome, Italy., Zanuzzi M; Italian Medicines Agency, Rome, Italy., Carletto A; Italian Medicines Agency, Rome, Italy., Sammarco A; Italian Medicines Agency, Rome, Italy., Romano F; Italian Medicines Agency, Rome, Italy., Russo P; Italian Medicines Agency, Rome, Italy.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2025 Mar; Vol. 12 (1), pp. 25-33. Date of Electronic Publication: 2024 Dec 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2199-1154
DOI:10.1007/s40801-024-00463-w